InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: silvr_surfr post# 14622

Wednesday, 11/22/2023 4:42:10 PM

Wednesday, November 22, 2023 4:42:10 PM

Post# of 14871
Thanks for CGOO70 info.
I agree Silvr, hopefully, the trial review is completed and posted within NIH guidelines (by October 27, 2023), and the analyst have their act together to pin them down on Testosterone, their stake in CG Oncology and royalty potential, and Sovuna and Corti 1% competitive advantages.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News